Skip to content

Bifonazole

DERMATOLOGICALS

Also known as: (+/-)-Bifonazole, bifazol, trifonazole

ATC D01AC10ATC D01AC60

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Bifonazole is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including CYP17A1, CYP51A1 and CYP3A4.

  • Molecular targets: CYP17A1, CYP51A1, CYP3A4 and IDO1 (4 listed in DrugCentral).
  • ATC code: D01AC10 (Imidazole and triazole derivatives).
  • Molecular formula: C22H18N2; molecular weight 310.40 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Steroid 17-alpha-hydroxylase/17,20 lyaseCYP17A1unknownKi 7.25
Lanosterol 14-alpha demethylaseCYP51A1unknownIC50 6.47
Cytochrome P450 3A4CYP3A4unknownIC50 6.10
Indoleamine 2,3-dioxygenase 1IDO1unknownIC50 4.64

ATC classification

ATC codeTherapeutic hierarchy
D01AC10DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives
D01AC60DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Bifonazole is on its molecule page.

Molecular formulaC22H18N2
Molecular weight310.40 g/mol
CAS number60628-96-8
InChIKeyOCAPBUJLXMYKEJ-UHFFFAOYSA-N
PubChem CID2378
C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Bifonazole work?

Its molecular targets in DrugCentral include CYP17A1, CYP51A1, CYP3A4 and IDO1.

What is the chemical formula of Bifonazole?

Bifonazole has the molecular formula C22H18N2 and a molecular weight of 310.40 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets4
Indications0
FormulaC22H18N2
DrugCentral ID370
Interactive profile